DNA甲基化与恶性血液病的研究进展
Progress of DNA methylation in malignant hematological disease
摘要
甲基化修饰是DNA的一种正常自然修饰方式,在基因表达的调控、基因结构的稳定等方面有不可或缺的地位。抑癌基因的高甲基化失表达在恶性血液病的发生发展过程中起着重要作用。甲基化研究可用于恶性血液病的诊断、抑癌基因的筛选、微小残留病灶的检测及疗效、预后判断,去甲基化治疗已成为恶性血液病治疗的又一重要途径。
出处
《国际儿科学杂志》
2009年第6期573-576,共4页
International Journal of Pediatrics
参考文献30
-
1Das PM, Singal R. DNA methylation and cancer. J Clin Oncol, 2004, 22 ( 22 ) : 4632-4642.
-
2Koyama M, Oka T, Ouchida M, et al. Activated proliferation of B-cell lymphomas/leukemias with the SHP1 gene silencing by aberrant CpG methylation. Lab Invest,2003,83(12) : 1849-1858.
-
3Wu C, Guan Q, Wang Y, et al. SHP-1 suppresses cancer cell growth by promoting degradation of JAK kinases. J Cell Biochem, 2003,90(5) :1026- 1037.
-
4Honorat JF, Ragab A, Lamant L, et al. SHP-1 tyrcsine phosphatease negatively regulates NPM-ALK tyrosine kinase signaling. Blood, 2006, 107 ( 10 ) : 4130-4138.
-
5Siu LL, Chum JK, Wong KF, et al. Specific patterns of gene methylation in natural killer cell lymphomas: p73 is consistently involved. Am J Pathol, 2002,160(1) :59-66.
-
6Shteper PJ,Ben-Yehuda D.Methylation of gene promoters in leukemogenesis.Isr Med Assoc J,2002,4( 11 ) : 1066-1071.
-
7Fleisher AS, Esteller M, Tamura G, et al. Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia. Oncogene, 2001,20(3 ) : 329-335.
-
8Reddy J, Shivapurkar N, Takahashi T, et al. Differential methylation of genes that regulate cytokine signaling in lymphoid and hematopoietic tumors. Oneogene, 2005,24(4) :732-736.
-
9Roman-Gomez J, Jimenez-Velasco A, Agirre X, et al. Lack of CpG island mothylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis. J Clin Oncol,2005, 23 ( 28 ) : 7043-7049.
-
10Roman-Gomez J, Castilejo JA, Jimenez A, et al. The role of DNA hyperm- ethylation in the pathogenesis and prognosis of acute lymphoblastic leukemia. Leuk Lymphoma, 2003,44( 11 ) : 1855-1864.
二级参考文献25
-
1罗建民,刘泽林,郝洪岭,董作仁,王福旭,大野竜三.急性白血病细胞HCP基因的突变分析[J].临床血液学杂志,2004,17(5):271-273. 被引量:6
-
2张凡,王燕,陈宝安,郑文莉,杜鹃,陆祖宏.定量检测E-cadherin基因启动子区甲基化芯片的建立[J].东南大学学报(医学版),2006,25(3):182-187. 被引量:2
-
3全国白血病化疗治疗讨论会.急性白血病疗效标准[J].中华血液学杂志,1988,9(3):183-183.
-
4Harms K,Nozell S,Chen X,et al.The common and distinct target genes of the p53 family transcription factors.Cell Mol Life Sci,2004,61(7-8):822-842
-
5Corn PG,Kuerbitz SJ,van Noesel MM,et al.Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5,CpG island methylation.Cancer Res,1999,59(14):3352-3356
-
6Kawano S,Miller CW,Gombart AF,et al.Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation.Blood,1999,94(3):1113-1120
-
7Liu M,Taketain T,Li R,et al.Loss of p73 gene expression in Lymphoid leukemia cell lines is associated with hypermethylation.Leuk Res,2001,25(6):441-447
-
8Uesugi Y, Fuse I, Toba K, et al. Involvement of SHP-1, a phosphotyrosine phosphatase, during myeloid cell differentiation in acute promyelocytic leukemia cell lines. Eur J Haematol, 1999, 62 :239-245.
-
9Dong Q, Siminovitch KA, Fialkow L, et al. Negative regulation of myeloid cell proliferation and function by the SH2 domain-containing tyrosine phosphatase-1. J Immunol, 1999, 162 : 3220-3230.
-
10Cascino I, Papoff G, Maria RD, et al. Fas/Apo-1 ( CD95 ) receptor lacking the intracytoplasmic signaling domain protects tomor cells from Fas-mediated apoptosis. J Immunol, 1996,156 : 13 - 17.
共引文献31
-
1高然,于锦香,高峰,蔡大利,王柏勋,潘登,张蕊,颜晓菁,李艳.地西他滨联合半量CAG治疗复发难治性急性髓细胞白血病的疗效分析[J].医学临床研究,2013,30(6):1125-1126. 被引量:1
-
2卢香兰,王萍萍,刘云鹏,李霞,侯科佐,刘静,岳瑶.三氧化二砷对人白血病细胞株NB4和K562及MOLt4的增殖、周期及凋亡的影响[J].肿瘤防治杂志,2004,11(6):586-588. 被引量:8
-
3李晓,应韶旭,石军,常春康,沈炜明,浦权,Tohyama Kaoru,HJ Deeg.三氧化二砷和肿瘤坏死因子相关凋亡诱导配体诱导的髓系恶性细胞系P15^(ink4b)表达[J].临床血液学杂志,2006,19(2):73-75. 被引量:1
-
4张学彦,刘铁夫,刘伟,崔希威.亚砷酸诱导人食管癌细胞株EC109细胞p15^(INK4B)基因的表达[J].世界华人消化杂志,2006,14(19):1859-1863. 被引量:2
-
5张品伟,李志刚,吴敏媛.DNA甲基化在白血病中临床研究进展[J].临床和实验医学杂志,2006,5(12):2028-2029.
-
6李英华,罗建民,张晓燕,王冬梅.SHP-1和JAK1基因在初治急性白血病患者中的表达[J].国际病理科学与临床杂志,2007,27(4):284-287. 被引量:2
-
7李英华,罗建民.SHP-1基因与白血病/淋巴瘤[J].国际病理科学与临床杂志,2007,27(6):507-510.
-
8冯翰雯,马梁明.三氧化二砷治疗复发性急性早幼粒细胞白血病14例[J].白血病.淋巴瘤,2007,16(3):225-226. 被引量:1
-
9罗建民,李燕,杨琳,刘小军,温树鹏,王福旭,张敬宇,张学军,董作仁.甲基化抑制剂5-aza-2′-deoxycytidine对K562细胞SHP-1基因表达及细胞增殖与凋亡的影响[J].中国实验血液学杂志,2009,17(2):309-314. 被引量:7
-
10罗建民,杨琳,李燕,刘小军,温树鹏,王福旭,张敬宇,张学军,杜行严,姚丽,董作仁.SHP-1与SOCS3基因在成人急性白血病中的表达及其与预后的关系[J].肿瘤防治研究,2009,36(5):384-387.
-
1陈存华,杨俊鹏.恶性血液病去甲基化治疗的研究进展[J].中国实验血液学杂志,2009,17(5):1394-1398. 被引量:3
-
2丁汀,章亮,金洁.硼替佐米治疗恶性血液病研究进展[J].健康研究,2009,29(1):70-74.
-
3郭宗明,谢兆霞.VEGF与恶性血液病的关系[J].国外医学(生理病理科学与临床分册),2004,24(2):183-185. 被引量:4
-
4Gutterman JU,伍先托.干扰素在恶性血液病治疗中的应用[J].国外医学(输血及血液学分册),1989,12(3):142-143.
-
5王小瑞,张红伟,郭春林,王永福.去甲基化在胃癌中的研究进展[J].国际消化病杂志,2010,30(5):273-275.
-
6朱立宁,徐岷,张尤历.DNA甲基化与胰腺癌的研究进展[J].国际消化病杂志,2012,32(2):104-106. 被引量:1
-
7王培培,张翠英.hMLH1、DAPK基因启动子区甲基化与肺癌耐药的相关性[J].肿瘤研究与临床,2016,28(3):207-209. 被引量:1
-
8吴春利,耿小平,朱立新.DNA甲基化与胆囊癌[J].国际外科学杂志,2008,35(8):568-571.
-
9李明,楼方定.DNA启动子甲基化与白血病的关系[J].国外医学(输血及血液学分册),2004,27(3):206-209. 被引量:3
-
10寿倍明,陈宝安,刘德龙.去甲基化在白血病上的研究进展[J].中国实验血液学杂志,2008,16(5):1247-1250. 被引量:11